New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about amylin analogs, retatrutide and more.

A simple change in how primary care clinics approach weight management is delivering big public health wins. PATHWEIGH lets patients openly request help and gives doctors the tools to focus entire ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. January has a funny way of making us ambitious.

Weight-loss experts reveal their major predictions for 2026, from advanced GLP-1 treatments to AI-driven personalized therapy ...

"I'm a whole new person." Read Molly's inspiring success story about ESG, a minimally invasive weight loss solution from Boston Scientific. Find a doctor today.

BOSTON — Starting in January, public workers and retirees enrolled in Group Insurance Commission plans will need to participate in a new program to maintain coverage for GLP-1 prescriptions as the ...

Noom Med is a medically-guided weight loss program that combines clinical care with Noom's behavior-change tools. The program provides virtual consultations, medication management, and nutrition ...

If you’re looking to create a healthier lifestyle, look no further than the power of running. Movement makes up a portion of the weight loss puzzle, and with our new Running for Weight Loss program, ...